Syringomahttps://en.wikipedia.org/wiki/Syringoma
Syringoma nyaéta tumor saluran kesang éccrine benign, ilaharna kapanggih dina kongkolak panon. Éta warna kulit atanapi semu konéng, benjolan buleud, diaméterna 1-3 mm, sareng tiasa dipatalikeun sareng xanthoma, milia, hidrocystoma, trichoepithelioma, sareng xanthelasma. Aranjeunna langkung umum di awéwé sareng paling sering dipendakan dina awéwé Asia tengah umur. Aranjeunna biasana henteu aya hubunganana sareng gejala anu sanés.

Perlakuan
#Pinhole technique (Erbium or CO2 laser)
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
  • Syringoma disorot ku bunderan bodas; Jenis lesion ieu paling sering lumangsung dina awéwé dina 40an sareng 50an. Pangobatan laser (pinhole method) tiasa mujarab pikeun ningkatkeun penampilan lesi.
    References Cutaneous Syringoma: A Clinicopathologic Study of 34 New Cases and Review of the Literature 23919023 
    NIH
    Tilu puluh opat pasien dibagi kana dua kelompok (localized and generalized syringoma) . Pasénna lolobana awéwé, salapan puluh tujuh persén, kalayan umur rata-rata 28 taun. Méméh neangan perlakuan, lesions geus hadir pikeun rata-rata genep taun. Generalized syringoma utamana mangaruhan dada jeung beuheung, tuluy leungeun, sedengkeun localized syringoma utamana kapanggih dina beungeut, axilla, jeung wewengkon séks.
    Thirty-four patients were sorted into two groups, localized and generalized syringoma, according to the Friedman and Butler classification. Ninety-seven percent of the patients were females with the mean age of 27.6 years. The mean duration of the lesions before the presentations was six years. Distribution of the generalized syringoma was mainly in the chest and neck followed by the forearms whereas localized syringoma was mostly confined to the face, axilla and genitalia.
     Syringoma: A Clinicopathologic and Immunohistologic Study and Results of Treatment 17326243 
    NIH
    Ulikan kami ditujukeun pikeun ngajelaskeun fitur klinis sareng histopatologi tina genep puluh hiji pasien anu didiagnosis sareng syringoma salami opat taun di klinik dermatologi urang di Korea. Kami mendakan yén syringoma kalolobaan kapangaruhan awéwé, kalayan rasio 6,6 awéwé ka 1 lalaki, sareng biasana muncul dina dékade kadua sareng katilu kahirupan dina langkung ti satengah pasien. Tempat anu paling sering kapangaruhan nyaéta kongkolak panon (71%) , sareng lesina lolobana warna kulit (49%) . Kami niténan penampilan anu sapertos tadpole dina 56% kasus. Hiperpigmentasi basal langkung umum dina lesi warna coklat, sedengkeun fibrosis langkung umum dina lesi erythematous. Salaku tambahan, kista keratin kirang umum dina kasus anu ngalibetkeun daérah séks.
    The purpose of our study was to describe clinical and histopathological features of sixty one patients with histological diagnosis of syringoma over four year period in our dermatology clinic in Korea. Female:male ratio was 6.6:1 with onset of age during 2nd and 3rd decades in more than half of the patients in our study. The most frequently involved site was eyelids (43 cases, 70.5%) and the most common color of lesion was skin-color (30 cases, 49.2%). In 34 cases, characteristic tad-pole appearances (55.7%) were observed. Basal hyperpigmentation was observed more frequently in brown-colored lesion (p=0.005). Fibrosis was observed more frequently in erythematous lesion (p=0.033). Keratin cyst was observed less frequently in genital involved group (p=0.006).
     Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia 37109186 
    NIH
    [Pinhole technique] - CO2 perlakuan laser ngagunakeun métode pinhole pikeun ngubaran telangiectasias raray mangrupakeun perlakuan aman, murah, jeung éféktif nu nyadiakeun penderita kalawan kapuasan estetika alus teuing.
    [Pinhole technique] - CO2 laser treatment using the pinhole method to treat facial telangiectasias is a safe, inexpensive, and effective treatment that provides patients with excellent aesthetic satisfaction.